BioMed Research International

BioMed Research International / 2019 / Article

Research Article | Open Access

Volume 2019 |Article ID 2098749 |

V. Shablii, M. Kuchma, H. Svitina, I. Skrypkina, P. Areshkov, V. Kyryk, T. Bukreieva, V. Nikulina, Iu. Shablii, G. Lobyntseva, "High Proliferative Placenta-Derived Multipotent Cells Express Cytokeratin 7 at Low Level", BioMed Research International, vol. 2019, Article ID 2098749, 13 pages, 2019.

High Proliferative Placenta-Derived Multipotent Cells Express Cytokeratin 7 at Low Level

Academic Editor: Richard Tucker
Received02 Nov 2018
Revised30 May 2019
Accepted25 Jun 2019
Published15 Jul 2019


The purpose of this study was to investigate the immunophenotypes and gene expression profile of high proliferative placenta-derived multipotent cells (PDMCs) population at different stages of culture. We demonstrated that the colonies resulting from single cells were either positive or negative for CK7, whereas only PDMC clones with weak CK7 expression (CK-clones) were highly proliferative. Interestingly, vimentin positive (Vim+) placental stromal mesenchymal cells did not express CK7 in situ, but double CK7+Vim+ cells detection in tissue explants and explants outgrowth indicated CK7 inducible expression in vitro. PCNA presence in CK7+Vim+ cells during placental explants culturing confirmed belonging of these cells to proliferative subpopulation. Transcription factors CDX2 and EOMES were expressed in both CK-clones and subset of stromal mesenchymal cells of first-trimester placental tissue in situ. Meanwhile, CK -clones and stromal mesenchymal cells of full-term placental tissue in situ expressed ERG heterogeneously. SPP1, COL2A1, and PPARG2 mesodermal-related genes expression by CK-clones additionally confirms their mesenchymal origin. Inherent stem cell-related gene expression (IFTM3, POU5F1, and VASA) in CK-clones might indicate their enrichment for progenitors. Finally, in CK-clones we observed expression of such trophoblast-associated genes as CGB types I and II, fusogenic ERVW-1, GCM1, and GATA3. Thus, our results indicate that PDMCs acquired the representative immunophenotype signature under culture conditions.

1. Introduction

Human placenta contains populations of different stem cell types, namely, the mesenchymal stem/stromal cells (MSC) [1], trophoblast stem cells [2], hematopoietic stem cells [3], and endothelial progenitor cells [4]. Compared to adult MSCs, placental ones possess advantages for regenerative medicine as faster kinetics, greater expansion potential, wider differentiation potential [5], and lower immunogenicity [6].

Based on pericyte markers CD146 and NG2 expression, the perivascular origin of foetal placental MSCs has been hypothesized [1, 3]. Additionally, the vascular origin of MSCs isolated from decidua basalis was confirmed by Kusuma et al., reporting presence of MSC markers 3G5, alpha-smooth muscle actin (αSMA), STRO-1, and FZD-9 around decidua basalis vessels ranging in size from 50 mm to 100 mm [7].

The different mesenchymal zones of the umbilical cord, such as Wharton's jelly zone, subamnioblastic zone, and subvascular zone, were characterized by expression of cytokeratins (CK) 7, 18, and 19 [8]. Along with aforementioned CK7 may be a marker of early mesoderm cells in extraembryonic tissues since the CK7+ mesodermal cells appeared after treatment of human ESCs with BMP4 and Activin/Nodal receptor inhibitor SB431542 [9]. Interestingly, CK7 was expressed in both adult hematopoietic stem cells and fetal liver (CD150+KSL) ones in vivo [10]. Furthermore, other mesodermal progenitors as fetal liver hepatic stellate cells [11] and mesothelial cells express the CK7 [12]. Therefore, mesenchymal stromal cells differ in expression of cytokeratins. Based on the heterogeneity of the placenta-derived multipotent cells (PDMCs) the expression of cytokeratins in the subset of placental mesenchymal progenitors remains unclear.

In addition to CK7, PDMC express other trophoblast-associated genes, namely, glial cell missing-1 (GCM1) and human chorionic gonadotropin alpha (αCG) [9], but, in contrast to trophoblasts, they are positive for vimentin (VIM) [13] and αSMA [1]. In spite of this, a large number of authors consider isolated cells in vitro as trophoblasts based on the detection of a limited list of trophoblast-associated genes: СК7, CK18, human chorionic gonadotropin beta (CGB), fusogenic gene ERVW-1, and transcription factor GCM1 [14].

We assume novel study of trophoblast- (GCM1, GATA3, ERVW1, and CGB), mesenchymal- (ERG, PPARG2, COL2A1, SPP1, Vim, and αSMA), and stemness-related (POU5F1, IFTM3, and VASA) markers expression in PDMCs and PDMC-derived clones at different stages of culturing may prompt the additional markers usage for evaluation of both trophoblast and MSCs culture purity.

Proceeding from the fact that development of the placenta is regulated by caudal type homeobox 2 (CDX2), eomesodermin (EOMES), and POU class 5 homeobox 1 (POU5F1) transcription factors [1518], we decided to focus on their expression in PDMCs and PDMC-derived clones.

2. Materials and Methods

This study and the consent procedure were approved by the Committee of Human Research of the Institute of Cell Therapy (#2-13).

Standard methods of adipogenic and osteogenic differentiation of PDMCs; RNA extraction; RT-PCR; karyotyping; and list of used primers and antibodies can be found in Supplementary Materials.

2.1. Isolation and Culture of PDMC

Term placentas (n=15; delivered after clinically normal pregnancies or Caesarean section) were collected from 23- to 36-year-old donors at 39–41 weeks of gestation in the Kyiv city maternity hospital #3. First-trimester placentas (n=7) were obtained from elective aborted human foetuses at 6 to 12 weeks of gestation with the women’s written informed consent (City Clinical Hospital #2, Kyiv). All donors provided written informed consent for the sourcing and the usage of their placentas and aborted foetal tissues for the approved study.

The amnion was removed, and an approximately 4 g fragment of chorionic plate and chorionic villus (3–7 mm thick) was cut off with scissors. The tissue fragment was minced into small pieces (1–3 mm) and washed intensively on a shaker in Hanks’ balanced salt solution (HBSS) (HyClone, USA) supplemented with penicillin (100 U/ml) and streptomycin (50 mg/ml) until the washing solution became colourless. Then, the fragments were digested with 0.1% collagenase I (Serva, Germany) and 0.6 U/ml dispase I (Gibco, USA) in 5 ml of DMEM (HyClone, USA) with 5 mM HEPES (MP Biomedicals, USA). Semidigested pieces of tissue were seeded into alpha-MEM (HyClone, USA) with an addition of 15% FBS (HyClone, USA), 1 × RPMI amino acid solution (Sigma, USA), and 1× streptomycin/penicillin (Sigma, USA), which completed the cultural medium. These explants were cultivated in cell culture flasks on an adhesive surface (Sarstedt, Germany) at +37°С and 5% СО2. Culture medium was changed twice a week. For immunohistochemistry the attached full-term placental tissue explants (FTPE) at 10 days were fixed in 4% PFA for 15 min at RT. When outgrowth of cells reached 80–90% confluence in a monolayer, they were detached using 0.05% trypsin and 0.02% EDTA (Biochrom, UK), washed, counted, and passaged at the inoculation density of 4–5 ×103 cells/cm2 on culture-treated surface plastic flasks, referred to as passage 1 (P1). PDMCs between the first and seventh passages were used for analysis (P1 through P7).

2.2. Obtaining PDMC Clones by Subsingle Cell Seeding

Every PDMCs suspension (from 4 individual donors) was diluted serially in alpha-MEM, and the last dilution corresponding to the concentration of 1 cell per 200 μl in complete medium was placed into each well of a 96-well tissue culture plate (Sarstedt, Germany) at the volume 100 μl. The culture medium was replaced at the day of culturing. At the , , , and days in culture, each well was observed by phase-contrast light microscopy to control the quality of cells. Only wells with single colonies of cells observed at day 3 and day 7 were maintained further by replacement of culture medium. Some colonies were isolated and subcultured. The majority of clones at P0 were seeded in two wells; one was used for immunocytochemistry detection of CK7, while another for further cell expansion. Several clones with high proliferative potential were propagated until cell senescence was observed or cells stopped proliferating. Immunocytochemistry was performed at all passages; gene expression and differentiation potential were tested at P5.

2.3. Flow Cytometry

Both PDMCs (from 10 individual donors) and single cell-derived clones (from 5 individual donors) were washed with cold Cell Wash buffer (Becton Dickinson, USA) and incubated for 30 min at +4°C with fluorochrome-conjugated monoclonal antibodies (Table S2) at an appropriate dilution of 0.5 μg per 106 cells.

Unbound primary antibodies were washed away with Cell Wash buffer. The samples were acquired on a BD FACSAria cell sorter (Becton Dickinson, USA) and analyzed using BD FACSDiva 6.1.2 software. To adjust the compensation settings of fluorochromes overlapping control samples were used: unstained control, single stained, and fluorescence minus one control.

2.4. Quantitative Real-Time RT-PCR

The relative gene expression level was conducted using a iCycler СFX96 Real-Time PCR system (Bio-Rad, USA) at standard conditions. Each qPCR reaction contained 1.5 μl cDNA, 0.3 μM of each specific primer (Table S1), and 1 × Maxima SYBR Green qPCR Master Mix (Thermo Scientific, USA) according to the manufacturer’s recommendations. PCR was performed under the following conditions: 10 min at 95°C, followed by 40 cycles of 15 s at 95°C, and 1 min at 60°C. No-template controls (NTCs) were used as negative controls. The specificity of the PCR primers was verified by melting curve and agarose gel analyses. If the difference between duplicate samples was greater than one cycle threshold the analysis was repeated. Obtained results from at least three separate experiments were normalized to the reference gene β-actin (ACTB). The relative levels of genes expression values were calculated using the method, where ΔΔCt=ΔC–ΔC [19].

2.5. Immunocytochemistry

PDMCs from individual donors (n=4) were grown on glass slides (Nunclon™Δ Surface, Sigma, USA), fixed in 4% PFA for 15 min at RT, and permeabilized in acetone/methanol solution (v/v 1:1) at -20°С for 40 min. Endogenous peroxidase activity was inhibited by incubation with 0.3%  Н2О2 for 5 min. Nonspecific antibodies binding was blocked by 0.5% BSA in 0.1 М PBS. Primary antibodies (Table S3) were applied in Antibody Diluent (S0809, Dako, Denmark) at +4°C overnight.

Visualization of specific binding was performed with the Mouse/Rabbit PolyVue HRP/DAB Detection System (Diagnostic BioSystems, USA). Images were captured using an inverted microscope (Olympus IX71, Olympus Corporation, Japan) at 50× magnification.

2.6. Immunofluorescence

PDMCs from individual donors (n=10) were fixed and permeabilized as described above. Nonspecific binding of antibodies was blocked by 0.5% BSA in 0.1 М PBS. After incubation with specific primary antibodies in PBS at +4°C overnight, appropriate Alexa 488 or Alexa 555 conjugated secondary antibodies (Table S3) were added for 1 h at RT. Confocal analysis was performed with a Zeiss LSM 510 Meta microscope (Carl Zeiss Microscopy GmbH, Germany) and images were captured with Zeiss LSM Image Browser software.

2.7. Immunohistochemistry Fluorescence

First-trimester placental tissue (FiTPT) at 7–11 weeks of gestation (n=7) and full-term placental tissue (FTPT, n=15) were fixed in 4% PFA for 24 h, embedded in paraffin, and sectioned according to standard histology methods. Paraffin-embedded tissues were deparaffinized in 2 changes of xylene and rehydrated in decreasing concentrations of ethanol.

Antigen retrieval was performed in Tris-EDTA buffer (10 mM Tris Base, 1 mM EDTA solution, pH 9.0) at +95°С for 30 min. Nonspecific reactivity was reduced by incubating tissue sections in blocking solution (0.5% BSA and 1% goat serum in 0.1 M PBS with 0.3% Triton X-100) for 30 min.

Immunostaining was accomplished by overnight incubation at +4°С with primary antibodies (Table S3) diluted in Antibody Diluent (Dako, Denmark). After extensive washing with 0.1 M PBS, samples were incubated in the appropriate species-specific secondary antibodies (Table S3) diluted 1:1000 in Antibody Diluent (Dako, Denmark) for 1 h at RT in the dark. After nuclear staining with Hoechst 33258 (Vector Laboratories, UK), slides were mounted in Mowiol® 4-88 (Sigma, USA).

Confocal analysis was performed with a Zeiss LSM 510 Meta microscope (Zeiss, Germany) and images were captured with Zeiss LSM Image Browser software.

2.8. Fluorescence In Situ Hybridization (FISH)

PDMCs from individual donors (n=4) were fixed on slides and digested with proteinase K before hybridization with human specific centromeric probe CEPХ SpectrumGreen probe and CEPY SpectrumOrange probe (Abbot Molecular, USA) according to the manufacturer’s protocol. Nuclei were counterstained with DAPI and viewed under an Olympus IX 71 fluorescence microscope (Olympus Corporation, Japan). A total of 500 cells per slide were analyzed.

2.9. Statistical Analysis

Results are represented as the means ± standard error for normally distributed data or medians with ranges for nonnormally distributed data. The significant differences between groups were assessed by two-tailed Student’s t-test or Mann–Whitney U-test, whenever applicable. P-values of <0.05 were considered to be significant.

3. Results

3.1. PDMCs Were of Foetal Origin

For more relevant interpretation of results, foetal cells of both sexes (n=10, 4 males and 6 females) were used in the research. FISH analysis confirmed the foetal origin of investigated cells, showing that all PDMCs from male newborns contained X and Y chromosomes in nuclei; the level of contamination by maternal cells was approximately 0.85% (0–3%, n=4) at P3 (Figure 1(a)). Chromosomal analysis of PDMCs populations (n=10) did not show any chromosomal abnormalities. All tested cells had normal karyotype, either male (46, XY) or female (46, XX) (Figure 1(b)).

3.2. PDMCs Expressed Proteins Typical of Trophoblast and Mesenchymal Cells

The flow cytometry analysis demonstrated that PDMCs (n=10) from P1 to P6 were positive for CD90, CD73, CD105, and HLA-ABC (Figure 1(c)) and negative for CD34, CD45, CD133, and CD14 (Figure 1(d)). However, the level of CD90 expression fluctuated from 73.8% to 98.3%. Some of the PDMC cultures (n=3) possessed bimodal patterns of CD90 expression and comprised both CD90+ and CD90- populations (Figure 1(e)). Multiparameter flow cytometry demonstrated a similar level of CD73 and CD105 expression on the cell surface of both CD90- and CD90+ subpopulations (Figure 1(e)).

PDMCs contain CK7+ cell population. Despite the fact that CK7-positive cytotrophoblasts are characterized by the lack of CD90 expression, almost all of CK7+ PDMCs (n=4) were positive for CD90 (Figure 1(f)). Additionally, multicolour flow cytometry of PDMCs showed expression of CD90 and CD105 on CK7+ cells (Figure 1(f)).

All PDMCs (n=10) simultaneously expressed VIM and pan-cytokeratin (pCK) during six passages of cultivation (Figure 1(g)). PDMCs (n=4) were heterogeneous for the expression of the epithelial cytoskeleton proteins CK18 (38%) and CK19 (31%) (Figure 1(g)), as well as the mesenchymal marker αSMA (65%) (Figure 1(g)).

The percentage of double positive cells for VIM and CK7 (Figure 1(g)) decreased significantly (p<0.05) from 37.6% (26.6–49.4%, n=6) at P1 to 13.4% (2.5–31.1%, n=6) at P3. We found that all PDMCs within six passages were positive for another trophoblast marker chorionic gonadotropin beta (CGB), which colocalized with VIM (Figure 1(g)).

All PDMCs (n=6) expressed CDX2 and EOMES, transcription factors equally critical for trophoblast and mesoderm development (Figure 1(g)). Both factors were localized predominantly in the cell nuclei, but a weak staining signal was also observed in the cytoplasm of some cells. Furthermore, we detected the nuclear localization of Ets-related gene product (ERG, Figure 1(g)) in more than 80% of PDMCs at P3 (n=5).

3.3. PDMCs Differentiated into Mesoderm Lineages

We have shown that PDMCs (n=4) at P3 had low capacity for osteogenic differentiation compared to adipogenic differentiation under appropriate induction conditions. Scattered nodules of extracellular calcium matrix were detected in PDMC cultures after osteogenic induction. In addition, the level of osteopontin expression under induction conditions did not differ in comparison to control (Figures 2(a) and 2(b)).

Analysis revealed the production of Oil Red O-positive lipid vacuoles in PDMCs when they were cultivated in adipogenic permissive medium for three weeks, and real-time PCR analysis showed significantly increased expression of adipocyte differentiation regulator PPARG2 (Figures 2(a) and 2(b)).

3.4. Characteristics of the PDMCs-Derived Clones

A total of 19 clones were isolated from three placenta samples and were either positive or negative for CK7 (Figure 3(a)). The percent of single cell-derived clones with low expression of CK7 (CK-clones), CK7+ clones and CK7- clones is 52% (n=10), 27% (n=5), and 21% (n=4), respectively.

CK-clones had the similar or higher proliferative characteristics in comparison to bulk PDMCs during more than ten passages (Figure S2A). It should be noted that at the passage the estimated total cell harvest ranged from 51.45×106 to 118.4×109 from CK-clones (Figure S2B). In contrast, both CK7+ and CK7- clones stopped to proliferate at P1. All clones lost the expression of CK7 at different times of propagation after the passage.

All CK-clones at P5 had the capacity to differentiate into adipogenic and osteogenic lineages (Figure 3(b)). The expression levels of adipogenesis- or osteogenesis-related genes, PPARG2 and SPP1, correspondingly, were significantly increased under appropriate differentiation conditions (Figure 3(c)).

The CK-clones (n=10) possessed CD90+CD73+CD105+CD44+CD45-CD34- surface immunophenotype (Figure S3) and expressed the mesoderm-related cytoskeleton proteins VIM and αSMA (Figure 3(d)). pCK was expressed in all CK-clones, but the expression of CK18 and CK19 was heterogeneous (Figure 3(d)). The transcription factors CDX2 and EOMES were detected in all CK-clones. In turn, we detected CDX2 in the nuclei of all cells during P3-P10 (Figure 3(d)). In addition, the expression of EOMES was positive in CK-clones with immunofluorescence signal in the nuclei of all cells during P3-P10 (Figure 3(d)). The Ck-clones were either positive (n=7) or negative (n=3) for ERG with strong nuclear localization (Figure 3(d)).

We detected expression of extraembryonic mesoderm-associated transcription factors CDX2, EOMES in all clones, but stem cells-related genes POU5F1 and VASA in CK-clones were expressed heterogeneously (Table S4); only three clones (PDMC-C1, PDMC-C6, and PDMC-C7) expressed all of these genes (Figure S1A). In contrast to VASA, another primordial germ cell marker, IFITM3, was common for all clones. Analysis of trophoblast-related genes (GCM1, GATA3, ERVW1, and CGB) expression profile (Figure S1A, Table S4) revealed GCM1, ERVW1, and GATA3 mRNAs were detected only in some CK-clones. The sequencing analysis showed that CGB in CK-clones was represented by either nontrophoblastic (type I) transcript type or type II (trophoblast-specific) transcripts (Figure S1B). Mesodermal-related genes SPP1, COL2A1, and PPARG2 were expressed in all CK-clones (Table S4).

3.5. FiTPT and FTPT Contained Cells with the Immunophenotype Similar to PDMCs

To investigate the origin of PDMCs, we performed immunohistochemistry on FiTPT, FTPT, and FTPE. Most of the cytokeratin-positive cells expressed CGB in FiTPT, in contrast to FTPT, where low levels of immunostaining signals for CGB were observed (Figure 4(a)).

Common mesenchymal marker VIM was detected in the stromal cells of chorion villi of FTPT and FiTPT, and all of them did not express CK7 (Figure 4(b)).

Although most CGB-positive cells did not express VIM, we detected some CGB+VIM+ cells in the stromal part of villous chorion of FTPT and FiTPT (Figure 4(c)). The subsequent experiments showed that all stromal CGB-positive cells were immunoreactive for CD68 antibodies, suggesting that VIM+CGB+ stromal cells were represented by a tissue-specific macrophage population distinct from PDMCs (Figure 4(d)). Therefore, stromal nonhematopoietic cells with expression profiles similar to PDMCs were not detected in FTPT and FiTPT in situ. We demonstrated that cells with PDMC-like immunophenotypes arose in FTPE. Indeed, all VIM+ cells in FTPE coexpressed CGB (Figure 5(a)). Additionally, VIM+CK7+ were detected in cells outgrowth from explants and were positive for proliferation marker PCNA (Figure 5(b)).

CDX2 was not detected in FTPT in situ. In the FiTPT, this transcription factor was strongly expressed in the nuclei of some cytotrophoblast cells (Figure 6(a)), and comparatively weakly in either cytoplasm or both cytoplasm and nucleus of stromal cells and syncytiotrophoblasts, depending on tissue sample (Figures 6(a) and 6(b)).

Notably, cell-type-specific expression of CDX2 was confirmed by detection of trophoblast (Figure 6(a)) and mesenchymal (Figure 6(b)) cell markers, pCK and VIM, correspondently. In double labelling for CDX2 and PCNA, we observed that CDX2+ cells were either positive or negative for this proliferation marker (Figure 6(c)). EOMES was observed in stromal cells and both cytotrophoblasts and syncytiotrophoblasts of FiTPT (Figure 7(a)).

Indeed, we found that EOMES-positive villous stromal cells were also positive for either VIM (Figure 7(b)) or αSMA (Figure 7(c)). EOMES was localized either in the cytoplasm or in both cytoplasm and nucleus of trophoblasts and stromal cells. Using dual labelling for EOMES and PCNA, we found that PCNA was confined to a subset of EOMES-positive cells (Figure 7(d)).

ERG-positive cells were found within the endothelial cells of FTPT and FiTPT (Figure 8(a)).

Using dual labelling for ERG and αSMA, we found that ERG was mostly absent in a subset of αSMA-positive cells, but in rare examples villous stromal cells were coexpressed both in FiTPT as well as in FTPT (Figure 8(b)).

Thus, we showed that CDX2 and EOMES were expressed in mesodermal and trophoblast cells of FiTPT, including proliferated stromal cells; ERG production in some stromal mesodermal nonendothelial cells in both FiTPT and FTPT; and inducible expression of several epithelial markers acquired under culture conditions ex vivo.

4. Discussion

Some PDMC lines showed bimodal distribution of CD90 expression. This phenomenon was previously observed [20, 21]. The expression of epithelial markers such as cytokeratins (pCK, CK18, CK19, and CK7) is likely to be a unique feature of PDMCs acquired under culture conditions. Although we showed that cytokeratins appeared in PDMCs in vitro, their expression was previously detected in umbilical cord-derived MSCs and in stromal cells of different compartments of umbilical cord in situ [22].

This study showed that both CK7+ and CK7- subpopulations of self-renewing PDMCs had low proliferative potential compared to cells with low expression of CK7. Indeed, clones that were negative for CK7 or strongly expressed this protein were not maintained in cell culture during passaging. Our presented data demonstrated the CK7 as monomers or granules in CK-clones in contrast to intermediate filament in CK7+ clones. Similar monomeric structure of cytokeratins is inherent in mitotic cells as shown by Toivola et al. [23]. However, it is interesting that the high proproliferative clones terminated the expression of CK7 after the third passage, which proves the unimportance of CK7 to maintain proliferative properties. Also, hematopoietic cells lost the expression of CK7 at early stages of differentiation, herewith they maintain the proliferation capacity [10]. Mesodermal origin mesothelium has two cell types, epithelial (mesothelial layer, expressing CK7) and fibroblast-like (subepithelial layer, lacking CK7). During mesothelial-mesenchymal transition epithelial markers are lost, including CK7, and cells acquiring the proliferative capacity [12, 24]. Choi et al. [25] showed that freshly isolated rat quiescent hepatic stellate cells expressed some epithelial markers, including E-cadherin, СК7, and СК19, which were downregulated during culture-induced transition to myofibroblastic hepatic stellate cells. Therefore, CK7 is inherent in various mesodermal progenitors but unimportant to maintain their proliferative capacity. We assume that CK7 expression at low level is characterized for placental mesenchymal progenitors at transition from quiescent to mitotic status rather than for maintenance of proliferation.

The belonging of CK7+Vim+ cells to a proliferative PDMCs subpopulation was confirmed by expression of PCNA in these cells during placental explants culture. The stromal mesenchymal (Vim+) cells did not express CK7 in situ, but double positive CK7+Vim+ cells were detected in tissue explants and explants outgrowth; hence, we conclude that expression of CK7 is induced in vitro. Moreover, the expression of CK7 was observed in the primary culture of amnion-derived MSCs and umbilical stromal cells in situ and ex vivo [22, 26]. To date, there is no data about the role of CK7 in the stem and progenitor cells of the mesodermal origin, nor the mechanism known to regulate the expression of CK7. It is known that the CK7 promoter contains PPAR response elements; at the same time in work by Ulrich et al. [27] and in our study the expression of this transcriptional factor was shown in PDMC. Induction PPARγ expression in mesenchymal placenta-derived cells occurred under culture conditions since in stromal cells PPARγ is not detected in situ [28, 29]. Thus PPARγ could be prominent trigger for CK7 expression during PDMC culture establishing.

In the present study, the expression of CDX2 and EOMES in the CK-clones was shown. In addition, we showed the expression of CDX2 and EOMES in proliferating subsets of chorionic mesenchymal (Vim+) cells of FiTPT in situ. The role of EOMES and CDX2 in the extraembryonic mesoderm development in humans is not studied sufficiently, but it is known that, in mice, CDX2 plays an essential role in posterior (somatic and extraembryonic) mesoderm development [30]. Thus, we conclude that CDX2 and EOMES are associated not only with trophoblast progenitors but also with mesenchymal progenitors of FiTPT in situ.

We observed either ERG-positive or -negative clones in the PDMC. Additionally, ERG was detected in both blood vessels and extravascular stromal cells of human FTPT and FiTPT. Although ERG mutation results in abnormal placenta development, including defective vasculature in the labyrinth region in mice [31], the role of this transcription factor in extraembryonic mesoderm development is insufficiently studied currently. We hypothesized that ERG expression in the PDMCs may attribute PDMCs to vasculogenic stromal cell population.

CK-clones expressed mesodermal-related genes SPP1, COL2A1, and PPARG2 [32], which additionally confirms their mesenchymal origin. Interestingly, these cells had inherent expression of the stem cell-related genes IFTM3 and VASA. Earlier, IFITM3 expression was already established in chorionic stem cells, but the expression of another gene involved in the maintenance of PGCs, VASA, was not observed in chorionic stem cells [33]. VASA is important for preserving totipotency by inhibiting the expression of genes that lead to somatic differentiation [34]. Also CK-clones expressed pluripotency marker POU5F1 that is common for pluripotent stem cells [35], and multipotent ectoderm [35], endoderm, and mesoderm precursors [14]. Detection of POU5F1, IFTM3, and VASA at the same time can testify that the CK-cell population is enriched in progenitors.

We have demonstrated that PDMCs and CK-clones expressed the following trophoblast-associated genes: GATA3, GCM1, ERVW1, and CGB. The role of these genes in PDMCs is unknown, but it is clear that they cannot be used as specific markers of trophoblast subpopulations in cell culture. Our data is consistent with Kumar et al. [36] which confirmed GATA3 expression in mesodermal progenitors, despite the fact that GATA3 is known to regulate trophoblast development [37]. Also, based on our results, we concluded that it is always necessary to investigate the expression of mesenchymal-related genes in trophoblast primary culture to avoid misinterpretations.

Therefore, a high-proliferative subpopulation of PDMCs weakly expresses CK7 and these cells acquire a specific immunophenotype because of their introduction into the cell culture.

5. Conclusions

Human PDMCs are a heterogeneous population of cells that possess immunophenotype and differentiation potential inherent in MSCs but, at the same time, express many genes commonly thought to be trophoblast associated. The subpopulation of PDMC with high proliferation potential and capacity to differentiate in mesodermal directions weakly expressed CK7. The transcription factors ERG, EOMES, and CDX2 are typically expressed in PDMCs and placental mesenchymal progenitors in situ. The PDMCs acquired its immunophenotype under culture conditions.


PDMC:Placenta-derived multipotent cells
FTPT:Full-term placental tissue
FiTPT:First-trimester placental tissue
FTPE:Full-term placental tissue explants
MSC:Mesenchymal stem/stromal cells
CDX2:Caudal type homeobox 2
ERVW1:Endogenous retrovirus group W member 1
GCM1:Glial cell missing -1
GATA3:GATA binding protein 3
POU5F1:POU class 5 homeobox 1
SPP1:Secreted phosphoprotein 1
PPARG2:Peroxisome proliferator activated receptor gamma
COL2A1:Collagen type II alpha 1 chain
IFTM3:Interferon induced transmembrane protein 3
VASA (DDX4):DEAD-box helicase 4
CGB:Chorionic gonadotropin beta subunit
PCNA:Proliferating cell nuclear antigen
ERG:Ets-related gene product
CK7:Cytokeratin 7
αSMA:Alpha-smooth muscle actin.

Data Availability

The data used to support the findings of this study are included within the article.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.


The authors thank the Director of Institute of Cell Therapy, Mr. S. Martynenko, for the help in the organization and support of this research. We are grateful to Dr. Zh. Misharina and Dr. V. Badiuk for assistance and advice in the FISH assay and karyotyping, respectively. The authors wish to thank Dr. P. Klymenko for assistance with placental tissue histology. Part of materials from this article was represented at the ISSCR 13th Annual Meeting in Stockholm, Sweden, in 2015, and at the IFPA “Placenta: Back to the Basics” meeting in Portland, Oregon, USA, 2016. This work was supported by the Institute of Cell Therapy and The National Academy of Sciences of Ukraine under Grant no. 0114U003877.

Supplementary Materials

Protocols of adipogenic and osteogenic differentiation, RNA extraction, RT-PCR, and karyotyping assays are provided. Table S1: Primers sequences and product sizes. Table S2: Antibodies used for cell characterization by flow cytometry. Table S3: Antibodies used for cell characterization by immunofluorescence. Figure S1: CK-clones expressed stemness-, mesoderm-, and trophoblast-related genes. Figure S2: Proliferative characteristics of CK-single cell-derived clones. Figure S3: CK- single cell-derived clones were positive for CD90, CD73, CD105, and CD44 and negative for CD34 and CD45 at P3. Table S4: The gene expression profile of CK-clones at P5. (Supplementary Materials)


  1. N. M. Castrechini, P. Murthi, N. M. Gude et al., “Mesenchymal stem cells in human placental chorionic villi reside in a vascular Niche,” Placenta, vol. 31, no. 3, pp. 203–212, 2010. View at: Publisher Site | Google Scholar
  2. R. M. Roberts and S. J. Fisher, “Trophoblast stem cells,” Biology of Reproduction, vol. 84, no. 3, pp. 412–421, 2011. View at: Publisher Site | Google Scholar
  3. C. Robin, K. Bollerot, S. Mendes et al., “Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development,” Cell Stem Cell, vol. 5, no. 4, pp. 385–395, 2009. View at: Publisher Site | Google Scholar
  4. B. M. Rapp, M. R. Saadatzedeh, R. H. Ofstein et al., “Resident endothelial progenitor cells from human placenta have greater vasculogenic potential than circulating endothelial progenitor cells from umbilical cord blood,” Cell Medicine, vol. 2, no. 1, pp. 85–96, 2011. View at: Publisher Site | Google Scholar
  5. Z.-Y. Zhang, S.-H. Teoh, M. S. K. Chong et al., “Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells,” Stem Cells, vol. 27, no. 1, pp. 126–137, 2009. View at: Publisher Site | Google Scholar
  6. A. Poloni, G. Maurizi, F. Serrani et al., “Human AB serum for generation of mesenchymal stem cells from human chorionic villi: Comparison with other source and other media including platelet lysate,” Cell Proliferation, vol. 45, no. 1, pp. 66–75, 2012. View at: Publisher Site | Google Scholar
  7. G. D. Kusuma, U. Manuelpillai, M. H. Abumaree, M. D. Pertile, S. P. Brennecke, and B. Kalionis, “Mesenchymal stem cells reside in a vascular niche in the decidua basalis and are absent in remodelled spiral arterioles,” Placenta, vol. 36, no. 3, pp. 312–321, 2015. View at: Publisher Site | Google Scholar
  8. Y. Li, M. Moretto-Zita, F. Soncin et al., “BMP4-directed trophoblast differentiation of human embryonic stem cells is mediated through a ΔNp63+ cytotrophoblast stem cell state,” Development, vol. 140, no. 19, pp. 3965–3976, 2013. View at: Publisher Site | Google Scholar
  9. A. S. Bernardo, T. Faial, L. Gardner et al., “BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages,” Cell Stem Cell, vol. 9, no. 2, pp. 144–155, 2011. View at: Publisher Site | Google Scholar
  10. Y. Tajima, K. Ito, A. Umino, A. C. Wilkinson, H. Nakauchi, and S. Yamazaki, “Continuous cell supply from Krt7-expressing hematopoietic stem cells during native hematopoiesis revealed by targeted in vivo gene transfer method,” Scientific Reports, vol. 7, no. 1, Article ID 40684, 2017. View at: Publisher Site | Google Scholar
  11. D. L. Suskind and M. O. Muench, “Searching for common stem cells of the hepatic and hematopoietic systems in the human fetal liver: CD34+ cytokeratin 7/8+ cells express markers for stellate cells,” Journal of Hepatology, vol. 40, no. 2, pp. 261–268, 2004. View at: Publisher Site | Google Scholar
  12. X. Sun, M. Gulyás, and A. Hjerpe, “Mesothelial differentiation as reflected by differential gene expression,” American Journal of Respiratory Cell and Molecular Biology, vol. 30, no. 4, pp. 510–518, 2004. View at: Publisher Site | Google Scholar
  13. C. D. Li, W. Y. Zhang, H. L. Li et al., “Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation,” Cell Research, vol. 15, no. 7, pp. 539–547, 2005. View at: Publisher Site | Google Scholar
  14. T. K. Gamage, L. W. Chamley, and J. L. James, “Stem cell insights into human trophoblast lineage differentiation,” Human Reproduction Update, vol. 23, no. 1, pp. 77–103, 2016. View at: Publisher Site | Google Scholar
  15. Y. Li, M. Moretto-Zita, F. Soncin et al., “BMP4-directed trophoblast differentiation of human embryonic stem cells is mediated through a ΔNp63 + cytotrophoblast stem cell state,” Development, vol. 140, no. 19, pp. 3965–3976, 2013. View at: Publisher Site | Google Scholar
  16. M. Hemberger, R. Udayashankar, P. Tesar, H. Moore, and G. J. Burton, “ELF5-enforced transcriptional networks define an epigenetically regulated trophoblast stem cell compartment in the human placenta,” Human Molecular Genetics, vol. 19, no. 12, pp. 2456–2467, 2010. View at: Publisher Site | Google Scholar
  17. O. Genbacev, M. Donne, M. Kapidzic et al., “Establishment of human trophoblast progenitor cell lines from the chorion,” Stem Cells, vol. 29, no. 9, pp. 1427–1436, 2011. View at: Publisher Site | Google Scholar
  18. J. van den Ameele, L. Tiberi, A. Bondue et al., “Eomesodermin induces Mesp1 expression and cardiac differentiation from embryonic stem cells in the absence of Activin,” EMBO Reports, vol. 13, no. 4, pp. 355–362, 2012. View at: Publisher Site | Google Scholar
  19. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at: Publisher Site | Google Scholar
  20. T. C. Tran, K. Kimura, M. Nagano et al., “Identification of human placenta-derived mesenchymal stem cells involved in re-endothelialization,” Journal of Cellular Physiology, vol. 226, no. 1, pp. 224–235, 2011. View at: Publisher Site | Google Scholar
  21. D. Campioni, R. Rizzo, M. Stignani et al., “A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs,” Cytometry Part B: Clinical Cytometry, vol. 76, no. 3, pp. 225–230, 2009. View at: Publisher Site | Google Scholar
  22. I. Garzón, C. A. Alfonso-Rodríguez, C. Martínez-Gómez et al., “Expression of epithelial markers by human umbilical cord stem cells. A topographical analysis,” Placenta, vol. 35, no. 12, pp. 994–1000, 2014. View at: Publisher Site | Google Scholar
  23. D. M. Toivola, Q. Zhou, L. S. English, M. B. Omary, and M. J. Solomon, “Type II keratins are phosphorylated on a unique motif during stress and mitosis in tissues and cultured cells,” Molecular Biology of the Cell, vol. 13, no. 6, pp. 1857–1870, 2002. View at: Publisher Site | Google Scholar
  24. S. E. Mutsaers, K. Birnie, S. Lansley, S. E. Herrick, C.-B. Lim, and C. M. Prêle, “Mesothelial cells in tissue repair and fibrosis,” Frontiers in Pharmacology, vol. 6, p. 113, 2015. View at: Google Scholar
  25. S. S. Choi, A. Omenetti, R. P. Witek et al., “Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 297, no. 6, pp. G1093–G1106, 2009. View at: Publisher Site | Google Scholar
  26. J. König, I. Lang, M. Siwetz, J. Fröhlich, and B. Huppertz, “Amnion-derived mesenchymal stromal cells show a mesenchymal–epithelial phenotype in culture,” Cell and Tissue Banking, vol. 15, no. 2, pp. 193–198, 2014. View at: Publisher Site | Google Scholar
  27. C. Ulrich, B. Rolauffs, H. Abele et al., “Low osteogenic differentiation potential of placenta-derived mesenchymal stromal cells correlates with low expression of the transcription factors Runx2 and Twist2,” Stem Cells and Development, vol. 22, no. 21, pp. 2859–2872, 2013. View at: Publisher Site | Google Scholar
  28. N. Segond, S. A. Degrelle, S. Berndt et al., “Transcriptome analysis of PPARγ target genes reveals the involvement of lysyl oxidase in human placental cytotrophoblast invasion,” PLoS ONE, vol. 8, no. 11, p. e79413, 2013. View at: Publisher Site | Google Scholar
  29. L. Capparuccia, D. Marzioni, A. Giordano et al., “PPARγ expression in normal human placenta, hydatidiform mole and choriocarcinoma,” Molecular Human Reproduction, vol. 8, no. 6, pp. 574–579, 2002. View at: Publisher Site | Google Scholar
  30. C. van Rooijen, S. Simmini, M. Bialecka et al., “Evolutionarily conserved requirement of Cdx for post-occipital tissue emergence,” Development, vol. 139, no. 14, pp. 2576–2583, 2012. View at: Publisher Site | Google Scholar
  31. P. Vijayaraj, A. Le Bras, N. Mitchell et al., “Erg is a crucial regulator of endocardial-mesenchymal transformation during cardiac valve morphogenesis,” Development, vol. 139, no. 21, pp. 3973–3985, 2012. View at: Publisher Site | Google Scholar
  32. I. Hue, D. Evain-Brion, T. Fournier, S. A. Degrelle, and C. E. Ambrósio, “Primary bovine extra-embryonic cultured cells: a new resource for the study of in vivo peri-implanting phenotypes and mesoderm formation,” PLoS ONE, vol. 10, no. 6, Article ID e0127330, 2015. View at: Publisher Site | Google Scholar
  33. G. N. Jones, D. Moschidou, T. Puga-Iglesias et al., “Ontological differences in first compared to third trimester human fetal placental chorionic stem cells,” PLoS ONE, vol. 7, no. 9, Article ID e43395, 2012. View at: Publisher Site | Google Scholar
  34. E. Raz, “The function and regulation of vasa-like genes in germ-cell development,” Genome Biology, vol. 1, no. 3, Article ID REVIEWS1017, 2000. View at: Google Scholar
  35. P. Noisa, T. S. Ramasamy, F. R. Lamont et al., “Identification and characterisation of the early differentiating cells in neural differentiation of human embryonic stem cells,” PLoS ONE, vol. 7, no. 5, Article ID e37129, 2012. View at: Publisher Site | Google Scholar
  36. N. Kumar, J. Richter, J. Cutts et al., “Generation of an expandable intermediate mesoderm restricted progenitor cell line from human pluripotent stem cells,” eLife, vol. 4, no. 2015, Article ID e08413, 2015. View at: Publisher Site | Google Scholar
  37. C. Krendl, D. Shaposhnikov, V. Rishko et al., “GATA2/3-TFAP2A/C transcription factor network couples human pluripotent stem cell differentiation to trophectoderm with repression of pluripotency,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 114, no. 45, pp. E9579–E9588, 2017. View at: Publisher Site | Google Scholar

Copyright © 2019 V. Shablii et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

739 Views | 282 Downloads | 0 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.